Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Goldman Sachs Downgrades American Homes 4 Rent Amid Market Oversupply Concerns

Felix Baarz by Felix Baarz
September 18, 2025
in Analysis, Real Estate & REITs, S&P 500
0
American Homes 4 Rent Stock
0
SHARES
141
VIEWS
Share on FacebookShare on Twitter

Goldman Sachs has revised its position on single-family rental operator American Homes 4 Rent (AMH), shifting its rating from “Buy” to “Neutral.” Concurrently, the investment bank has reduced its price target for the company’s shares from $43 to $37. This decision stems from mounting apprehensions regarding a surplus of rental properties entering the market and the subsequent pressure this is placing on rental rate growth.

Oversupply Dynamics Challenge Sector Outlook

According to analysis by Goldman Sachs strategist Julien Blouin, the current environment is becoming increasingly challenging for residential real estate equities. A significant influx of single-family homes is appearing on the rental market within American Homes 4 Rent’s key operational areas. The report details a trend where home sellers are becoming “involuntary landlords,” and homebuilders are opting to convert properties originally intended for sale into rental units.

This emerging “shadow supply” of rental homes is now substantially outpacing tenant demand in these critical regions. The resulting imbalance is exerting downward pressure on achievable rental rates, directly impacting the revenue potential for companies like American Homes 4 Rent.

Financial Forecasts Adjusted Below Consensus

In light of these market conditions, Goldman Sachs has downwardly revised its core Funds From Operations (FFO) projections for AMH. The updated estimates now sit 0.7% below the market consensus for 2025 and a full 2.0% below for 2026.

The specific adjustments are:
* 2025 Forecast: Reduced by 0.1%
* 2026 Forecast: Reduced by 1.9%

Should investors sell immediately? Or is it worth buying American Homes 4 Rent?

The analyst team believes current market expectations are underestimating the seasonal slowdown in new lease rates anticipated for the latter half of 2025. Furthermore, they contend that projections may be overestimating the acceleration in lease renewal rates expected in the first half of 2026.

Mixed Sentiment Persists Among Analysts

The downgrade from Goldman Sachs presents a contrasting view to other firms covering the stock, highlighting a divided analytical landscape.

  • Evercore ISI maintains an “Outperform” rating, though it slightly trimmed its price target from $41 to $40.
  • Mizuho continues to recommend “Outperform” but lowered its target from $38 to $36, citing concerns over property taxes.
  • Citizens JMP reaffirmed its “Market Outperform” rating and a $41 price objective following the company’s robust second-quarter performance.

AMH demonstrated significant operational strength in Q2, reporting earnings per share (EPS) of $0.28, which handily exceeded the $0.17 forecast. Revenue for the quarter reached $457.5 million.

The critical question for investors is whether American Homes 4 Rent can overcome the negative momentum identified by Goldman Sachs. The coming weeks will be pivotal in determining if these concerns are warranted or if the company’s underlying operational performance will prevail.

Ad

American Homes 4 Rent Stock: Buy or Sell?! New American Homes 4 Rent Analysis from February 7 delivers the answer:

The latest American Homes 4 Rent figures speak for themselves: Urgent action needed for American Homes 4 Rent investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

American Homes 4 Rent: Buy or sell? Read more here...

Tags: American Homes 4 Rent
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

February 7, 2026
Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Next Post
Regency Centers Stock

Regency Centers Gains Analyst Favor Through Strategic Development Push

Agree Realty Stock

A Defensive Powerhouse: Agree Realty's Strategic Edge in Net-Lease Investing

Alpine Immune Sciences Stock

Vertex Pharmaceuticals Secures Future Pipeline with $4.9 Billion Alpine Immune Sciences Acquisition

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com